rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-3-8
|
pubmed:abstractText |
Exemestane (Aromasin) is an irreversible aromatase inactivator used for the treatment of postmenopausal women with advanced breast cancer. The objective of this study was to evaluate the effect of formulation comparing a sugar-coated tablet (SCT) with a suspension and food on the pharmacokinetics (PK) and pharmacodynamics (PD) with respect to plasma estrone sulphate (E1S) concentrations of exemestane, using a PK/PD approach.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-10735887,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-10882163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11396363,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11668120,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-11854020,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12093316,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12186378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-12357147,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2124648,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2146284,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-2375613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-3289052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-6352137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-7479205,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8043491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8388198,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-8502825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9274439,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9365185,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9542479,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9748124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9815789,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9823425,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9828250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15752382-9871428
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0306-5251
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
355-64
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15752382-Administration, Oral,
pubmed-meshheading:15752382-Aged,
pubmed-meshheading:15752382-Androstadienes,
pubmed-meshheading:15752382-Antineoplastic Agents,
pubmed-meshheading:15752382-Aromatase Inhibitors,
pubmed-meshheading:15752382-Chemistry, Pharmaceutical,
pubmed-meshheading:15752382-Cross-Over Studies,
pubmed-meshheading:15752382-Fasting,
pubmed-meshheading:15752382-Female,
pubmed-meshheading:15752382-Food-Drug Interactions,
pubmed-meshheading:15752382-Humans,
pubmed-meshheading:15752382-Middle Aged
|
pubmed:year |
2005
|
pubmed:articleTitle |
A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation.
|
pubmed:affiliation |
Department of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco, CA-94143, USA. MValle@hsp.santpau.es
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|